News from medimmune A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 26, 2013, 10:01 ET MedImmune's FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal), Four-Strain, Nasal-Spray Flu Vaccine, Ships for 2013-2014 Influenza Season

MedImmune, the global biologics research and development arm of AstraZeneca, announced today that it began shipping FluMist Quadrivalent to influenza ...


May 04, 2013, 10:00 ET MedImmune To Present Seven Posters On Influenza, Respiratory Syncytial Virus At The Annual Pediatric Academic Societies Meeting

MedImmune announced today it will conduct seven poster and/or presentations at the Pediatric Academic Societies (PAS) Meeting at the Walter E....


Dec 17, 2012, 09:00 ET MedImmune Announces Agreement with Progenics Pharmaceuticals to Develop Therapies Against Serious Bacterial Infections

MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals, Inc....


Oct 19, 2012, 03:00 ET MedImmune To Present Three Influenza Abstracts At The IDWeek 2012 Meeting

MedImmune, the global biologics arm of AstraZeneca, announced today it will present three influenza abstracts at IDWeek 2012: the first combined...


Oct 09, 2012, 11:30 ET MedImmune To Present Four Flu Abstracts At The Influenza Vaccines For The World Conference

MedImmune, the global biologics arm of AstraZeneca, announced today it will present four abstracts at the Influenza Vaccines for the World (IVW)...


Oct 09, 2012, 09:00 ET MedImmune Joins Forces With Leading Cancer Organizations to Advance Novel Immunotherapy Research

The Cancer Research Institute (CRI), the Ludwig Institute for Cancer Research and MedImmune, the global biologics arm of AstraZeneca, today announced ...


Oct 03, 2012, 12:30 ET Study In Journal of Medical Economics Shows Palivizumab Cost Effectiveness Using FDA-approved Dosing And AAP Red Book

MedImmune, the biologics arm of AstraZeneca, today announced that the Journal of Medical Economics has published a study that shows Synagis®...


Sep 10, 2012, 06:00 ET MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market

MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outsourcing company, today announced that...


Aug 02, 2012, 10:30 ET FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping For 2012-2013 Influenza Season

MedImmune, the global biologics arm of AstraZeneca, announced it began shipping FluMist® to influenza vaccine distributors throughout the United...


Jul 10, 2012, 10:00 ET MedImmune And KaBOOM! Team Up To Build New Playground At The Children's Inn At NIH

Summer is a time to play and July 23rd is when The Children's Inn at NIH will get a fabulous new playground thanks to the generosity of MedImmune and ...


May 01, 2012, 10:44 ET New Study Demonstrates Dosing Non-Compliance Increases RSV-Related Hospitalizations Among High-Risk Babies In Medicaid Population

MedImmune, the global biologics arm of AstraZeneca, announced results from a new retrospective database cohort study of 8,443 high-risk infants...


Feb 29, 2012, 07:20 ET MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)

MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)...


Nov 14, 2011, 11:00 ET MedImmune Announces Winners of Its 6th Annual Global Abstract Competition

MedImmune today announced the winners of its 6th Annual Research Abstract Competition highlighting the work of the next generation of scientific...


Nov 08, 2011, 07:00 ET MedImmune Manufacturing Facility Recognized as 2011 Facility of the Year in Pharmaceutical Engineering

MedImmune, the global biologics arm of AstraZeneca, today announced that the company's expansion project at its Frederick, Md., Manufacturing Center...


Nov 03, 2011, 11:19 ET MedImmune annonce les vainqueurs de son concours européen de résumés de recherche sur le cancer

?MedImmune a dévoilé aujourd'hui les noms des lauréats de son concours européen annuel de résumés de recherche sur le cancer, qui reconnaît la...


Nov 03, 2011, 11:16 ET MedImmune annuncia i vincitori del concorso European Cancer Research Abstract Competition

?Oggi edImmune ha annunciato i vincitori del concorso European Cancer Research Abstract Competition che premia ricerche importanti condotte da...


Nov 03, 2011, 11:13 ET MedImmune gibt Gewinner des europäischen Forschungswettbewerbs für Abstracts im Bereich Krebsforschung bekannt

?MedImmune gab heute die Gewinner seines alljährlich stattfindenden europäischen Wettbewerbs bekannt, in dessen Rahmen herausragende...


Nov 02, 2011, 14:13 ET MedImmune anuncia los ganadores de la European Cancer Research Abstract Competition

MedImmune anunció hoy a los ganadores de su European Cancer Research Abstract Competition anual, que reconoce la investigación destacada de los...


Oct 21, 2011, 12:00 ET MedImmune to Present Phase 3 Pediatric Clinical Data for Quadrivalent Influenza at 49th Annual IDSA Meeting

MedImmune announced today it will present results of a Phase 3 pediatric clinical study of its investigational quadrivalent live attenuated influenza ...


Oct 03, 2011, 08:00 ET MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer

MedImmune, the global biologics arm of AstraZeneca, today announced execution of an in-licensing agreement with Pfizer Inc for tremelimumab...


Jul 18, 2011, 12:00 ET FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping for 2011-2012 Influenza Season

MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service...


Jul 18, 2011, 06:00 ET MedImmune Submits Supplemental Biologics License Application for Quadrivalent Seasonal Nasal Spray Influenza Vaccine

MedImmune has received confirmation from the U.S. Food & Drug Administration (FDA) that the Agency has filed the Company's supplemental Biologics...


May 01, 2011, 09:00 ET MedImmune to Present Eleven Abstracts on Influenza and Respiratory Syncytial Virus at the Annual Pediatric Academic Societies Meeting

MedImmune announced today it will present 11 abstracts at the Pediatric Academic Societies (PAS) Meeting at the Colorado Convention Center in Denver, ...


Mar 29, 2011, 10:25 ET MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference

MedImmune announced today it will present a total of 11 abstracts at the 45th National Immunization Conference (NIC) at the Washington Hilton in...


Jan 20, 2011, 08:30 ET Investigational Compound Offers Novel Anti-IGF Approach To Inhibit Growth of Cancer Cells

MedImmune's Oncology group announced today preclinical results showing that MEDI-573, a targeted monoclonal antibody, broadly suppresses pathways...